These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11494443)
1. [Experience in the use of vessel due F (sulodexide) in patients with suppurative-necrotic forms of diabetic foot without critical ischemia]. Svetukhin AM; Zemlianoĭ AB; Orudzheva SA; Titova MI; Rudneva VG; Elagina LV; Pavlova MV; Terekhova RP; Bozh'eva EI; Makhmudova LS Ter Arkh; 2001; 73(4):31-3. PubMed ID: 11494443 [TBL] [Abstract][Full Text] [Related]
2. [Substantiation and varieties of complex surgical treatment tactics for pyo-necrotic forms of diabetic foot]. Zemlianoĭ AB; Pal'tsyn AA; Svetukhin AM; Korotkina RN; Elagina LV; Pavlova MV; Terekhova RP; Kolokol'chikova EG; Bozh'eva EI; Makhmudova LS; Lebedeva AN; Ivanov LO Khirurgiia (Mosk); 1999; (10):44-8. PubMed ID: 10540553 [TBL] [Abstract][Full Text] [Related]
3. [Sulodexide in the treatment of diabetic nephropathy]. Rasovskiĭ BL; Tarasov AV; Trel'skaia NIu; Severina TI; Chernykh EF Klin Med (Mosk); 1998; 76(7):40-2. PubMed ID: 9742778 [TBL] [Abstract][Full Text] [Related]
4. The effect of insulin and sulodexide (Vessel Due F) on diabetic foot syndrome: pilot study in elderly patients. Koblik T; Sieradzki J; Sendur R; Biernat J; Czarnobilski K; Gryz E; Pawlik W; Szczudlik A; Gaddi A J Diabetes Complications; 2001; 15(2):69-74. PubMed ID: 11274902 [TBL] [Abstract][Full Text] [Related]
5. Microvascular changes in the diabetic foot. Schramm JC; Dinh T; Veves A Int J Low Extrem Wounds; 2006 Sep; 5(3):149-59. PubMed ID: 16928671 [TBL] [Abstract][Full Text] [Related]
6. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy. Lambers Heerspink HJ; Fowler MJ; Volgi J; Reutens AT; Klein I; Herskovits TA; Packham DK; Fraser IR; Schwartz SL; Abaterusso C; Lewis J; Diabet Med; 2007 Nov; 24(11):1290-5. PubMed ID: 17956455 [TBL] [Abstract][Full Text] [Related]
7. [Use of CO2 laser in the treatment of suppurative-necrotic lesions of the foot in patients with diabetes mellitus]. Danil'iants EV; Khazin AD; Smakov SB; Gorev VK Khirurgiia (Mosk); 1989 Oct; (10):71-4. PubMed ID: 2593579 [TBL] [Abstract][Full Text] [Related]
8. [NO-therapy in the treatment of purulent and necrotic lesions of lower extremities in diabetic patients]. Shulutko AM; Antropova NV; Kriuger IuA Khirurgiia (Mosk); 2004; (12):43-6. PubMed ID: 15699957 [TBL] [Abstract][Full Text] [Related]
9. [Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities]. Utratová J; Mayer J; Elbl L; Vorlícek J; Prásek J Vnitr Lek; 1993 Jun; 39(6):575-80. PubMed ID: 8212613 [TBL] [Abstract][Full Text] [Related]
10. Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulceration. Weck M; Rietzsch H; Lawall H; Pichlmeier U; Bramlage P; Schellong S Thromb Haemost; 2008 Sep; 100(3):475-82. PubMed ID: 18766265 [TBL] [Abstract][Full Text] [Related]
11. [Sulodexide in the treatment of right hand necrosis in diabetic patient performing exchanges of continuous ambulatory peritoneal dialysis (CAPD) by himself]. Olszowska A; Pietrzak B; Wańkowicz Z Pol Merkur Lekarski; 1998 Nov; 5(29):301-3. PubMed ID: 10101507 [TBL] [Abstract][Full Text] [Related]
12. Microcirculation in the diabetic foot as measured by a multichannel laser Doppler instrument. Karnafel W; Juskowa J; Maniewski R; Liebert A; Jasik M; Zbieć A Med Sci Monit; 2002 Jul; 8(7):MT137-44. PubMed ID: 12118211 [TBL] [Abstract][Full Text] [Related]
13. [Syndrome of diabetic foot and atherosclerosis of the lower extremity arteries]. Kokobelian AR; Zigmantovich IuM Vestn Khir Im I I Grek; 2006; 165(3):74-8. PubMed ID: 16881182 [TBL] [Abstract][Full Text] [Related]
14. Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria. Heerspink HL; Greene T; Lewis JB; Raz I; Rohde RD; Hunsicker LG; Schwartz SL; Aronoff S; Katz MA; Eisner GM; Mersey JH; Wiegmann TB; Nephrol Dial Transplant; 2008 Jun; 23(6):1946-54. PubMed ID: 18089623 [TBL] [Abstract][Full Text] [Related]
15. [Central hemodynamics during epidural anesthesia in patients with pyonecrotic forms of diabetic foot]. Orudzheva SA; Chistov AS; Zviagin AA; Sashurina LP Anesteziol Reanimatol; 2002; (3):39-41. PubMed ID: 12221875 [TBL] [Abstract][Full Text] [Related]
16. [Application of air-plasma flow for the correction of microcirculation disorders during the treatment of diabetic foot syndrome]. Duvanskiĭ VA; Dzagnidze NS Georgian Med News; 2005 Dec; (129):12-6. PubMed ID: 16444019 [TBL] [Abstract][Full Text] [Related]
17. Haemodialysis is associated with changes in cutaneous microcirculation in diabetes mellitus. Beckert S; Sundermann K; Wolf S; Königsrainer A; Coerper S Diabet Med; 2009 Jan; 26(1):89-92. PubMed ID: 19125767 [TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis and combined surgical treatment of the pyonecrotic diabetic foot]. Svetukhin AM; Zemlianoĭ AB; Istratov VG; Korotkina RN; Terekhova RP; Puchkova LS; Makhmudova LS Khirurgiia (Mosk); 2003; (3):85-8. PubMed ID: 12698661 [TBL] [Abstract][Full Text] [Related]
19. Microvascular dysfunction in diabetic foot disease and ulceration. Chao CY; Cheing GL Diabetes Metab Res Rev; 2009 Oct; 25(7):604-14. PubMed ID: 19681035 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of diabetic patients with necrotic lesions of the foot]. Astakhova IN Khirurgiia (Mosk); 2001; (12):34-7. PubMed ID: 11810937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]